Abstract

The aim of the study was to determine the influence of the SarsCov2 virus on the spread of the black fungus, a dangerous and even deadly disease that spreads mainly in Asia. The etiology of this disease, symptoms and diagnosis, clinical significance, identification, relationships between this disease and diabetes and coronavirus infection are discussed. In addition, treatment and prevention options were analyzed, especially in patients with chromoblastomycosis, as well as prophylaxis. Patients with diabetic ketoacidosis have been shown to be at a higher risk of developing the black fungus known as Mucormycosis. Patients with a positive coronavirus test are also exposed to black fungus infection. The disease spreads through the respiratory tract, affecting people with weakened immune systems and those treated with steroids. Black fungus symptoms vary depending on where it resides, leading to a variety of facial and cerebral symptoms. It has been established that the fungus does not spread between humans or between humans and animals, but is usually found in people who are immunocompromised or are taking medications that reduce the body's ability to fight germs and diseases. Mucormycosis, in conditions of high humidity and high temperature, can prove fatal as the risk of transmission increases, especially in the event of the SarsCov 2 pandemic. In the near future, this fungus could pose a very real problem to human health worldwide You are worth the top fake watches UK with high quality!
With low price and high quality, the US cheap replica breitling watches are worth having!
You can buy 1:1 Swiss made fake watches UK here with low prices!

References

1. Alastruey-Izquierdo, OA, Arenz AD, et al. (2019). Global guidelines for the diagnosis and treatment of Mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group. Educational and research consortium. Lancet Infection Dis 2019, 19, e405–21
2. Song, Y., Qiao, J., Giovanni, G., Liu, G., Yang, H., Wu, J., & Chen, J. (2017). Mucormycosis in renal transplant recipients: review of 174 reported cases. BMC infectious diseases, 17(1), 283. https://doi.org/10.1186/s12879-017-2381-1 (accessed June 9, 2021).
3. UNICEF & ESARO (2021), Social listening report on online conversations in Eastern and Southern Africa, COVID-19 and its impacts – Online conversations in ESAR, pp. 21. https://reliefweb.int/sites/reliefweb.int/files/resourc es/social_listening_report_-_monthly_covid19_and_its_impacts_may_202123369.pdf (accessed: June 9, 2021).
4. Kumar, A., Singh, R., Shashank, S., Joshi R. & Misra A. (2021), Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, https://doi.org/10.1016/j.dsx.2021.05.019. (accessed June 9, 2021).
5. Li DM, Li RY, de Hoog GS, Sudhadham M, Wang DL. (2011). Fatal Exophiala infections in China, with a report of seven cases. Mycoses. 2011, 54 (4): 136–42.
6. Parakash H., Chakrabarti A. (2021). Epidemiology of Mucormycosis in India. Microorganisms 2021; 9: 523.2 @DVSadanandGowda. May 26, 2021. https://twitter.com/DVSadanandGowda/status/1397 438818999296259 (accessed June 9, 2021 (accessed 21.06.2021
7. Raithel M., Weidenhiller M, Hagel AF, Hetterich U, Neurath MF, Konturek PC. (2013). Malabsorption of common mono- and disaccharides: levels of testing and differential diagnosis. Dtsch Arztebl Int. 2013; 110 (46): 775–782.
8. Roden M.M., Zaoutis T.E., Buchanan W.L., et al. (2005). Epidemiology and Outcomes of Zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005, 41, 634–53.
9. Rodrigues ML, Albuquerque PC. (2018). Seeking change: The need for increased support for public health and research into fungal diseases. PLoS Negl Trop Dis 2018; 12: e0006479.
10. Seneviratne CJ., Fong PHL., Wong, SWW., Lee FHV., (2015). Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy. BMC Oral Health 2015, 15:39 DOI 10.1186/s12903-015-0023-9.
11. NORD (National Organization for Rare Disorders). Disease rare disease database 2018, https://rarediseases.org/rare-diseases/mucormycosis (accessed: June 22, 2021)
12. Danion F, Aguilar C, Catherinot E, et al. (2015). Mucormycosis: new lesions leading to a persistently debilitating infection. Semin Respir Crit Care Med 2015; 36: 692-705. https://www.ncbi.nlm.nih.gov/pubmed/26398536.
13. Binder U, Mauer E, Lass-Florl C. (2014). Mucormycosis - from pathogens to disease. Infection with microbiol Clin. 2014; 20: 60-66. https://www.ncbi.nlm.nih.gov/pubmed/24476149.
14. Katragkou A, Walsh TJ, Roilides E. (2014). Why is mucormycosis more difficult to treat than more frequent mycoses? Infection with microbiol Clin. 2014; 20: 74-81. https://www.ncbi.nlm.nih.gov/pubmed/24279587.
15. Skiada A, Lanternier F, Groll AH, et al. (2013). Diagnosis and treatment of mucormycosis in patients with haematological malignancies: guidelines from the 3rd European Conference on Leukemia Infections (ECIL 3). Hematological. 2013; 98: 492-504. https://www.ncbi.nlm.nih.gov/pubmed/22983580.
16. Woo PC, Ngan AH, Tsang CC, Ling IW, Chan JF, Leung SY, et al. (2013). Clinical spectrum of Exophiala infections and a novel Exophiala species, Exophiala hongkongensis. J Clin Microbiol. 2013;51, 260–267.
17. Wang CY, Neil LD, Home, P. (2018) Vision 2020 - An overview of the outlook for diabetes management and prevention for the next decade. Diabetes Research and Clinical Practice 2018, 143, 101-112. DOI: 10.1016 / j.diabres. 2018.06.007.
18. Mahomoodally, M.F. Subratty, A.H. Gurib-Fakim, A., Choudhary, M.I., Khan, S.N., 2012. Traditional Medicinal Herbs and Food Plants Have the Potential to Inhibit Key Carbohydrate Hydrolyzing Enzymes In Vitro and Reduce Postprandial Blood Glucose Peaks In Vivo. The Scientific World Journal Volume 2012, 9 pp., doi: 10.1100/2012/285284
19. Sawicka B., Gupta PD., (2018). Importance of dietary fiber and starch in the prevention of selected civilization diseases: A Review. Journal of Cell and Tissue Research 2018, 18(2), 6485-6489.
20. Rattanakiat, S., Pulbutr, P., Khunawattanakul W., Sungthong B., Saramunee K. (2020). Prebiotic activity of polysaccharides extracted from Jerusalem artichoke tubers and development of prebiotic granules, Pharmacognosy Journal 2020,12 (6): 1402–1413. DOI: 10.5530 / pj.2020.12.194